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Abstract
Background: Human gastrointestinal mucosa regenerates vigorously throughout life, but the
factors controlling cell fate in mature mucosa are poorly understood. GATA transcription factors
direct cell proliferation and differentiation in many organs, and are implicated in tumorigenesis.
GATA-4 and GATA-6 are considered crucial for the formation of murine gastrointestinal mucosa,
but their role in human gastrointestinal tract remains unexplored. We studied in detail the
expression patterns of these two GATA factors and a GATA-6 down-stream target, Indian
hedgehog (Ihh), in normal human gastrointestinal mucosa. Since these factors are considered
important for proliferation and differentiation, we also explored the possible alterations in their
expression in gastrointestinal neoplasias. The expression of the carcinogenesis-related protein
Indian hedgehog was also investigated in comparison to GATA factors.
Methods: Samples of normal and neoplastic gastrointestinal tract from children and adults were
subjected to RNA in situ hybridization with 33P labelled probes and immunohistochemistry, using
an avidin-biotin immunoperoxidase system. The pathological tissues examined included samples of
chronic and atrophic gastritis as well as adenomas and adenocarcinomas of the colon and rectum.
Results: GATA-4 was abundant in the differentiated epithelial cells of the proximal parts of the
gastrointestinal tract but was absent from the distal parts. In contrast, GATA-6 was expressed
throughout the gastrointestinal epithelium, and in the distal gut its expression was most intense at
the bottom of the crypts, i.e. cells with proliferative capacity. Both factors were also present in
Barrett's esophagus and metaplasia of the stomach. GATA-6 expression was reduced in colon
carcinoma. Ihh expression overlapped with that of GATA-6 especially in benign gastrointestinal
neoplasias.
Conclusion: The results suggest differential but overlapping functions for GATA-4 and GATA-6
in the normal gastrointestinal mucosa. Furthermore, GATA-4, GATA-6 and Ihh expression is
altered in premalignant dysplastic lesions and reduced in overt cancer.
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Background
The structure of human gastrointestinal mucosa is highly
complex. The mucosal morphology and enzymatic func-
tion are reached mainly during mid-gestation, but the
mucosa undergoes regeneration throughout life. The
mature mucosa comprises multipotent stem cells, their
immediate progeny, and various differentiated cell types
that serve digestive, absorptive, or immunologic func-
tions. The maintenance of mucosal homeostasis requires
a balance between rapid regeneration and cell turnover.
Little is known, however, about the factors determining
tissue renewal and cell fate in the gastrointestinal tract.
GATA proteins are zinc finger transcription factors that
regulate cellular development and differentiation. The
GATA family contains six members; GATA-1, GATA-2, and
GATA-3 function mainly in hematopoietic cell lineages
[1], whereas GATA-4, GATA-5, and GATA-6 are found in
organs of endodermal origin [2]. In the gastrointestinal
tract, GATA-4 and GATA-6 are present from the onset of
formation of the primitive gut tube through the organiza-
tion of normal postnatal epithelium [3-6]. GATA-4 is con-
sidered to be one of the first transcription factors binding
to chromatin during early endodermal differentiation [7].
This binding has been proposed to initiate the opening of
the chromatin and enable the binding of other transcrip-
tion factors to DNA [8]. Mice with targeted deletion of
Gata4 or Gata6 die during early embryonic development:
GATA-6 is crucial in the development of visceral endo-
derm, whereas GATA-4 is needed for the formation of the
heart tube [4,9].
GATA-4 and GATA-6 are both believed to facilitate the ter-
minal differentiation of the epithelium of the intestinal
villi [10]. In mice chimeric for Gata4 -/- and wild type
cells, the gastric epithelial lineages were found to differen-
tiate poorly during embryonic development [6]. In mice
harbouring a tissue-specific deletion of Gata4 in the gut,
jejunal gene expression was noted to change to the ileal-
type, underscoring the role of GATA-4 in the development
of the proximal small intestine [11]. In the gastrointesti-
nal tract, GATA proteins regulate a variety of target genes
involved in digestive functions and tissue regeneration.
For example, two genes expressed in enterocytes of the
small intestine, lactase phlorizin hydrolase (LPH) and
fatty acid binding protein (FABP), are regulated by GATA-
4, GATA-5, and GATA-6 [12-15]. Moreover, GATA factors
are related to gastroprotective Trefoil Factor Family (TFF)
peptides and mucin protein genes expressed in the stom-
ach and colon mucosa [16,17].
In addition to normal growth, GATA proteins have been
proposed to be associated with tumorigenesis in the
adrenals, lungs and ovaries [18-20]. GATA-6 upregulates
expression of Indian hedgehog (Ihh) [21]; the hedgehog
signalling is known to be critical for proper gut morpho-
genesis [22]. Ihh is present in mature human gastric and
colon epithelium [23,24], and its expression is altered
during carcinogenesis of the gastrointestinal tract [23-25].
The role of Ihh in tumor biology, however, remains con-
troversial. Ihh is believed to stimulate proliferation and
induce carcinogenesis in the gastrointestinal tract [25,26],
but it may also act as an antagonist of the Wnt-pathway to
restrict tumor progression [23].
In this study we compare the expression of GATA-4,
GATA-6, and Ihh in normal and pathological human gas-
trointestinal tissue samples. We show that GATA-4, GATA-
6 and Ihh have particular expression patterns in the gas-
trointestinal mucosa, depending on the segment in the
longitudinal or crypt-villus axis, as well as the specific cell
type. In addition, the expression patterns of these factors
in gastrointestinal neoplasms differ from those in the nor-
mal gastrointestinal tract. We suggest that GATA-4 and
GATA-6 may maintain normal tissue renewal and differ-
entiation in mature gastrointestinal mucosa and that
alterations in their expression accompany premalignant
and malignant changes in the gut mucosa.
Methods
Normal samples
Normal gastrointestinal biopsy specimens were obtained
during esophagogastroduodenoscopy and colonoscopy
performed for diagnostic purposes. The specimens (Table
1) included tissue from gastric, duodenal, ileal, colonic
and rectal mucosa. Most of the samples (37 out of 55)
were collected from children. All biopsy specimens were
diagnosed as morphologically normal by a pathologist.
Table 1: Patients' ages and the number of normal gastrointestinal samples as to the methods used
Tissue Age (yr) Range (median) GATA-4 GATA-6 Ihh3
IHC1 ISH2 IHC1 ISH2 IHC1
Stomach 0.95 – 91.0 (15.4) 11 6 10 7 7
Duodenum 0.95 – 73.0 (11.6) 16 9 14 8 8
Ileum 6.08 – 76.0 (31.0) 8 3 7 3 4
Colon 5.90 – 76.0 (13.9) 8 6 7 6 2
Rectum 0.04 – 13.91 (6.89) 6 9 3 8 1
Abbreviations: 1IHC = immunohistochemistry, 2ISH = in situ hybridization, 3Ihh = Indian hedgehogBMC Gastroenterology 2008, 8:9 http://www.biomedcentral.com/1471-230X/8/9
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Pathological samples
The pathological samples from distal esophagus and
stomach were collected during routine esophagogastrodu-
odenoscopy from adult patients with chronic and
atrophic gastritis (Table 2). Esophageal biopsies con-
tained intestinal metaplasia (also called Barrett's esopha-
gus), a precancerous state of the esophageal epithelium.
Neuroendocrine cell hyperplasia was found in three stom-
ach samples. Colon and rectum samples were obtained in
resections for adenomas and primary adenocarcinomas.
Some of them contained dysplasia (n = 5) and invasive
carcinoma (n = 2).
Tissue preparation and ethical considerations
Tissue specimens, originally collected for diagnostic pur-
poses, were fixed in formalin and embedded in paraffin
for further investigations, then cut into 6-μm sections,
coded, and evaluated; the evaluator had no knowledge of
the specimen. The specimens used for in situ hybdization
experiments were frozen in liquid nitrogen and stored at -
70°C until used. The use of the samples in this study was
approved by the Ethics Committee of the Hospital for
Children and Adolescents and the Ethics Committee of
the Department of Internal Medicine, Helsinki University
Central Hospital, and the Finnish National Authority of
Medicolegal Affairs.
In situ hybridization
Radioactive in situ hybridization was performed on nor-
mal gastrointestinal samples (Table 1). Paraffin embed-
ded tissue sections (n = 22) were deparaffinized, and
frozen sections (n = 9) were fixed in 40 g/L paraformalde-
hyde in phosphate-buffered saline (PBS). We applied the
procedure described earlier [27]. Human GATA-4 and
GATA-6 cDNAs were prepared as previously described
[28]. Tissue sections were incubated with antisense or
sense riboprobes labeled with 33P (1.2 × 106  cpm,
1000–3000 Ci/mmol, Amersham Pharmacia Biotech,
Arlington Heights, IL) in a total volume of 80 μl. The
slides were assessed by three researchers independently
and blinded under a dark field light microscope (Leica
DMRXA microscope, Leica, Switzerland).
Immunohistochemistry
Deparaffinized sections of normal and pathological tissue
(Tables 1 and 2) were dehydrated, and antigen retrieval
was improved by microwave cooking for 20 min in 10
mM citric acid, pH 6. The endogenous peroxidase reaction
was inhibited by treatment with 3 g/L of H2O2. The sec-
tions were then subjected to immunohistochemistry,
using polyclonal goat anti-human GATA-4 (sc-1237, dilu-
tion 1:200) or Ihh (sc-1196, dilution 1:50) antibodies, or
polyclonal rabbit anti-human GATA-6 antibody (sc-9055,
dilution 1:50). The antibodies were from Santa Cruz Bio-
technology (Santa Cruz, CA). The specificity of the stain-
ing was assessed using preimmune serum or PBS instead
of the primary antibody during the staining protocol. In
addition, our earlier studies with consecutive samples for
RNA in situ hybridization and immunohistochemistry on
adrenal samples have revealed the reliability of the used
anti-GATA-4 and anti-GATA-6 antibodies in human tis-
sues [28]. In some instances, GATA-6 gives a cytoplasmic
staining as previously reported [15]. Although cytoplas-
mic staining for GATA proteins usually has not been con-
sidered specific, there is also some evidence that GATA
proteins are not always transported to the nucleus imme-
diately after translation [29]. The avidin-biotin immu-
noperoxidase system (Vectastain Elite ABC Kit, Vector
laboratories, Burlingame, CA) and 3,3'-diaminobenzi-
dine (Sigma-Aldrich, St. Louis, MO) were used to visualize
antibody binding. The tissues were counterstained with
Harris hematoxylin. The Alcian blue/periodic acid-Schiff
Table 2: Description of the neoplastic samples subjected to GATA-4, GATA-6 and Ihh immunohistochemistry
Tissue Diagnosis Age (yr) median (range) Number of samples
Esophagus
Barrett's esophagus 65 (55–83) 9
Stomach
Chronic gastritis, intestinal metaplasia 67 (56–73) 5
Chronic gastritis, intestinal metaplasia, neuroendocrine cell hyperplasia 52 (49–54) 2
Intestinal metaplasia, neuroendocrine cell hyperplasia 69 1
Colon
Dysplasia 41 1
Adenoma serratum, dysplasia 77 1
Adenoma tubulovillosum, dysplasia 47 (28–73) 3
Adenocarcinoma, low grade 54 (41–87) 3
Adenocarcinoma, moderate grade 71 (47–79) 5
Adenocarcinoma, high grade 76 (72–80) 2
Rectum
Adenocarcinoma, high grade 83 1
Adenocarcinoma, moderate grade 79 1BMC Gastroenterology 2008, 8:9 http://www.biomedcentral.com/1471-230X/8/9
Page 4 of 13
(page number not for citation purposes)
staining method and hematoxylin-eosin staining were
used to detect goblet and Paneth cells, respectively. These
results were compared with GATA immunohistochemis-
try. All the slides were analysed under a light microscope
(Leica DMRXA microscope) and reassessed by a patholo-
gist.
Double immunostaining
The double-staining method was performed on normal
paraffin-embedded sections. The sections were prepared
as described above, with the following modifications:
After staining for GATA-4 (sc-1237) or GATA-6 (sc-9055)
with 3,3'-diaminobenzidine, the slides were incubated
with the second primary antibody for 1 h at +37°C. The
second primary antibody was either a polyclonal goat
anti-human chromogranin A antibody (sc-1488, dilution
1:50, Santa Cruz Biotechnology) used to detect neuroen-
docrine cells in stomach, duodenum, and large intestine,
or monoclonal anti-human hydrogen/potassium adenos-
ine triphosphatase (H+/K+-ATPase) antibody against α
(119102, dilution 1:50, Calbiochem®, EMD Chemicals
Inc., Darmstadt, Germany) or β subunit (MA3-923, dilu-
tion 1:1000, Affinity BioReagents Inc., Golden, CO) to
identify the parietal cells in the stomach. The immunore-
activity was visualised by Vector SG® (Vector Laborato-
ries).
Results
GATA-4 and GATA-6 have differential mRNA expression in 
normal gastrointestinal mucosa
GATA-4 and GATA-6 mRNA expression was first analyzed
in the normal gastrointestinal mucosa by in situ hybridi-
zation. Samples representing stomach, duodenum, termi-
nal ileum, colon, and rectum showed differences in the
expression of GATA-4 and GATA-6 along the longitudinal
axis and the crypt-villus axis. GATA-4 mRNA was abun-
dant in the superficial two thirds of the mucosa of the
proximal gastrointestinal tract (Fig. 1A-A' and 1C-C') but
was absent from the distal gut (Fig. 1E-E' and 1G-G'). In
contrast, GATA-6 mRNA was highly expressed in the basal
regions of the mucosa along the whole gastrointestinal
tract, diminishing somewhat towards the distal end (Fig.
1B-B', 1D-D', 1F-F', and 1H-H', data on rectum not
shown).
GATA-4 and GATA-6 protein expression show cell type 
specificity along the normal human gastrointestinal tract
Immunostaining was used to delineate the gastrointesti-
nal cell types expressing GATA-4 and GATA-6. GATA-6
immunoreactivity was widespread in the mucosa. In the
corpus, GATA-6 expression was abundant in the glands,
consisting of chief cells and parietal cells (Fig. 2B with
inset). In the antrum and pylorus, the staining for GATA-
4 was strongest in the neck and surface epithelium, dimin-
ishing towards the base, where GATA-6 exhibited moder-
ate immunoreactivity. In the duodenum, there was no
significant GATA-4 immunoreactivity in the Brunner
glands, which were positive for GATA-6 (data not shown),
but enterocytes lining the villi were highly GATA-4 posi-
tive (Fig. 2D). GATA-6 predominated in the crypts of Lie-
berkühn (Fig. 2E). The mucosa of the terminal ileum (Fig.
2G), colon (Fig. 2J) and rectum (data not shown) gener-
ally lacked GATA-4 protein. In 3 out of 17 ileum and
colon samples, however, a faint staining for GATA-4 was
detected in the epithelium adjacent to a lymph node. Dis-
tinct positivity for GATA-6 was detected especially in the
bottom of the crypts of the distal gut (Fig. 2K). It is note-
worthy that neither GATA-4 nor GATA-6 was found in
neuroendocrine cells along the gastrointestinal tract
(Fig.3A, 3A', 3C, 3C', 3F, and 3F'). Thus, GATA-4 and
GATA-6 presented a cell-specific expression pattern
throughout the gastrointestinal tract (Table 3). There were
no age-dependent differences in the expression patterns.
Ihh is expressed in normal gastrointestinal mucosa
In the stomach, Ihh expression resembled that of GATA-6;
the glandular region, especially in the corpus, showed
strong immunoreactivity for Ihh (Fig. 2C). Apart from
intense Ihh expression in the neuroendocrine cells
throughout the GI tract (Fig. 2F and 2I, arrowheads), the
gut mucosa was mostly Ihh-negative. Staining along the
brush border of the villus was considered non-specific.
Only occasional villus and crypt enterocytes of the small
intestine (Fig. 2F) as well as colonocytes and lamina pro-
pria of the superficial colon mucosa showed immunore-
activity for Ihh (Fig. 2L, arrowhead).
GATA-4, GATA-6, and Ihh expression is induced in 
Barrett's esophagus and intestinal metaplasia of the 
stomach
GATA-4 and Ihh were not found in normal squamous epi-
thelium of the esophagus, while GATA-6 was expressed in
the epithelium near the gastroesophageal junction (data
not shown). Barrett's esophagus (data not shown) as well
as intestinal metaplasia of the stomach were nevertheless
highly positive for GATA-4, GATA-6 and Ihh (Fig. 4A, 4A',
and 4A").
GATA-4 and GATA-6, but not Ihh, are strongly expressed 
in hyperplastic neuroendocrine cells of atrophic stomach 
mucosa
Neuroendocrine cell hyperplasia was present in 3 atrophic
gastric samples. As described above, normal neuroendo-
crine cells expressed neither GATA-4 nor GATA-6 but were
positive for Ihh. On the other hand, hyperplastic neuroen-
docrine cells strongly expressed both GATA-4 and GATA-
6 (Fig. 4B and 4B'). Interestingly, Ihh expression was weak
or absent in these hyperplastic clusters of neuroendocrine
cells (Fig. 4B").BMC Gastroenterology 2008, 8:9 http://www.biomedcentral.com/1471-230X/8/9
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GATA-6 and Ihh are expressed in dysplastic lesions and 
adenomas of the colon
No expression of GATA-4 was detected in dysplastic
lesions or adenomas of the colon (Fig. 4C). In contrast,
GATA-6 was positive in colon adenomas and low grade
dysplasias; moreover, GATA-6 expression was intense in
high grade dysplasias (Fig. 4C' with inset). The expression
pattern of Ihh in tubulovillous adenomas and epithelial
dysplasias resembled that of GATA-6 (Fig. 4C" with inset).
Ihh was not detected in serrated adenoma (data not
shown).
GATA-4 and GATA-6 mRNA expression in normal gastrointestinal mucosa Figure 1
GATA-4 and GATA-6 mRNA expression in normal gastrointestinal mucosa. Both bright and dark field in situ 
hybridization views are shown. In the stomach (A, A', B, and B'), GATA-4 mRNA expression is strongest in the middle and 
superficial layers (A-A'), while GATA-6 mRNA expression is most abundant in the basal two thirds of the mucosa (B-B'). In the 
duodenum, the enterocytes lining the villi are strongly positive for GATA-4 (C-C'), whereas the GATA-6 signal is more diffuse 
(D and D'). GATA-4 is no longer detected in the ileum (E and E') and colon (G and G'); the bright lining on the surface of the 
mucosa is due to tissue autofluorescence (E-E' and G-G'). In contrast, GATA-6 expression is prominent both in the small (D, 
D', F, and F') and large intestine (H and H') presenting positivity in the surface and crypt enterocytes, and the cells of the lamina 
propria (D-D', F-F', and H-H'). Scale bar = 50 μm. Abbreviations: STO = stomach, DUO = duodenum, ILE = ileum, COL = 
colon.BMC Gastroenterology 2008, 8:9 http://www.biomedcentral.com/1471-230X/8/9
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GATA-4, GATA-6, and Ihh protein expression in normal gastrointestinal mucosa Figure 2
GATA-4, GATA-6, and Ihh protein expression in normal gastrointestinal mucosa. Brown nuclear staining indicates 
positivity for GATA-4 and GATA-6, and brown cytoplasmic color positivity for Ihh. In contrast to GATA-4 (A), GATA-6 (B) 
and Ihh (C) are strongly expressed at the bottom of the gastric glands (A, B, and C with insets). In the duodenum (D and E), 
both GATA-4 and GATA-6 are abundant in the villus enterocytes (D and E). In the ileum (G and H) and colon (J and K), 
GATA-4 is undetectable (G and J), whereas GATA-6 is abundant in the enterocytes, especially in the crypts (H and K). Some 
GATA-6 positivity is detected also in the lamina propria. Ihh expression is intense in intraepithelial neuroendocrine cells of the 
small intestine. Positivity can also be seen in some inflammatory cells of lamina propria, though non-specific absorption by 
plasma cells cannot be ruled out (F and I, arrowheads). In the colon, the enterocytes and the superficial compartments of the 
lamina propria are weakly positive for Ihh (L, arrowheads). Scale bars: Black = 200 μm and yellow = 25 μm. Abbreviations: STO 
= stomach, DUO = duodenum, ILE = ileum, COL = colon.BMC Gastroenterology 2008, 8:9 http://www.biomedcentral.com/1471-230X/8/9
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GATA-6 expression is low in colon carcinoma
In colon carcinoma, only low GATA-6 expression was
detected (Fig. 4D'), and there was no correlation to histo-
logical grade of the tumor (Table 4). GATA-6 expression
seemed to be diminished in carcinoma cells as compared
to the adjacent normal colon mucosa. On the contrary,
our results suggest that GATA-6 expression is stronger in
the parts of the carcinoma nearest the surrounding
stroma, i.e., in areas representing the invasive edge of the
tumor (data not shown). GATA-4 and Ihh were not
present in any of the colon carcinoma samples studied
(Fig. 4D and 4D").
Discussion
Transcription factors play an important role in cell prolif-
eration and differentiation, and consequently in tissue
repair. We studied the expression of two GATA transcrip-
tion factors in human gastrointestinal tract in detail. As
our samples were derived from both children and adults,
the wide age variation may have influenced the results. It
Identification of different cell types expressing GATA-4 and GATA-6 proteins in normal gastrointestinal mucosa Figure 3
Identification of different cell types expressing GATA-4 and GATA-6 proteins in normal gastrointestinal 
mucosa. Staining for chromogranin A (ChrA) (blue-greyish cytoplasmic staining in A, A', C, C', F, and F') was used to detect 
neuroendocrine cells and staining for H+/K+-ATPase α (HK) (blue-greyish cytoplasmic staining in B and B' to detect parietal 
cells. The samples were double-stained for GATA-4 (G4) or GATA-6 (G6) (brown nuclear staining). The GATA proteins are 
not expressed in the neuroendocrine cells of the stomach, duodenum, or colon (A, A', C, C', F and F' respectively; arrow-
heads). GATA-4 is detected in the H+/K+-ATPase α presenting parietal cells (B). GATA-6 is positive in approximately two 
thirds of the parietal cells positive for H+/K+-ATPase α (B', arrowheads). Some duodenal goblet cells, stained deep blue by the 
Alcian blue method (Alc) (D'), and most Paneth cells are positive for GATA-6 (E', arrowhead) showing no immunoreactivity for 
GATA-4 (D and E, arrowheads). Scale bar = 50 μm.
GATA-6
A. Chr+G4 B. HK+G4
C. Chr+G4
E. G4  F. Chr+G4
A'. Chr+G6 B'. HK+G6
C'. Chr+G6 D'. Alc
E'. G6 F'. Chr+G6
GATA-4
D. Alc G4 G6
‹
‹
‹
‹
‹
‹
‹
‹
‹
‹BMC Gastroenterology 2008, 8:9 http://www.biomedcentral.com/1471-230X/8/9
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is noteworthy, however, that in murine gastrointestinal
tract, GATA-4 and GATA-6 expression patterns are rather
stable from birth to adulthood [30].
In mature gastrointestinal mucosa, new cells are continu-
ously generated from multipotent stem cells. Although
the exact location of the stem cells of the gastrointestinal
mucosa has not been determined, it has been suggested
that in the stomach they lie in the isthmus, whereas in the
intestine they may be located deeper in the crypts. The
proliferating descendants of the stem cells enter the differ-
entiation pathway and migrate into their specific sites in
the mucosa. The cells eventually undergo apoptosis and
are shed into the gut lumen [31]. It is of interest that the
strongest GATA-6 expression occurs in the basal regions of
the gut mucosa including cells with the highest prolifera-
tive capacity. Although GATA-6 expression has earlier
been thought to decrease during enterocyte differentia-
tion in vitro [10], we found GATA-6 in all mucosal layers,
including the areas of highly differentiated cells. Ihh has
been suggested to be regulated in part by GATA-6 [21],
and we find that the expression patterns of these two fac-
tors partly overlap in the gut. In contrast to GATA-6,
GATA-4 was localized to more differentiated cells (this
study) [10]. In the murine small intestine, GATA-4 expres-
sion diminishes towards the villus tips the low expression
thus associating with areas of apoptosis [15]. In cardiac
myocytes, GATA-4 is related to anti-apoptotic factors [32],
and its down-regulation is proposed to be essential for
apoptosis [33]. We therefore suggest that the absence of
GATA-4 from the villus tip enables enterocyte apoptosis
and exfoliation of senescent cells.
In chronic gastrointestinal inflammation, such as
esophagitis and gastritis, the renewal of normal tissue is
disturbed, possibly leading to neoplastic tissue growth
[34]. Interestingly, the expression of GATA-4, GATA-6 and
Ihh appear to increase in two precancerous lesions such as
Barrett's esophagus and intestinal metaplasias of the
stomach. GATA-4 and GATA-6 are also expressed in
hyperplastic neuroendocrine cells associated with
atrophic gastritis. Some researchers have linked GATA-6 to
normal murine neuroendocrine cells [35,36], but we
Table 4: The expression patterns for GATA-4, GATA-6 and Ihh in gastrointestinal neoplasias
Tissue Diagnosis GATA-4 GATA-6 Ihh
Esophagus (n = 9)
Barrett's esophagus +++ +++ ++
Stomach (n = 8)
Intestinal metaplasia +++ +++ ++
Neuroendocrine cell hyperplasia ++ +++ -
Colon (n = 15)
Adenoma, low grade dysplasia - + +
Adenoma, high grade dysplasia - ++ ++
Adenocarcinoma, low/moderate grade - + -
Adenocarcinoma, high grade - + -
The expression patterns are based on the number of positive cells detected and the intensity of staining:
- no expression
+ individual positive cells or small areas with low expression
++ patches of moderate expression
+++ large areas of moderate or strong expression
Table 3: The expression of GATA-4 and GATA-6 in different cell 
types of the gastrointestinal mucosa on the basis of conventional 
and double immunohistochemistry
Tissue Cell type GATA-4 GATA-6
Stomach
Corpus
Surface epithelial cells ++ ++
Neck cells +++ ++
Parietal cells +++ ++
Neuroendocrine cells - -
Antrum
Surface epithelial cells ++ +
Neck cells +++ ++
Glandular cells ++ +++
Neuroendocrine cells - -
Duodenum
Villus enterocytes +++ ++
Crypt enterocytes ++ +++
Neuroendocrine cells - -
Goblet cells - +
Paneth cells - ++
Colon
Surface colonocytes - +
Crypt cells - +++
Goblet cells - ++
Neuroendocrine cells - -
The expression patterns based on the number of positive cells 
detected:
- no expression,
+ low expression; <20% of the cells positive
++ moderate expression; 20–60% of the cells positive
+++ abundant expression; >60% of the cells positiveBMC Gastroenterology 2008, 8:9 http://www.biomedcentral.com/1471-230X/8/9
Page 9 of 13
(page number not for citation purposes)
detected neither GATA-4 nor GATA-6 in these cells (this
study). The appearance of GATA factors in neuroendo-
crine cell hyperplasia raises the question of whether they
contribute to the progression of neuroendocrine neo-
plasms. Interestingly, GATA factors have been shown to
downregulate HDC [37] encoding a histamine synthesiz-
ing enzyme found in both normal and, in increasing
amounts, in neoplastic neuroendocrine tissues [38].
In contrast to metaplasias of the proximal gastrointestinal
tract, GATA-4 is not present in colon tumors, whereas
GATA-6 and Ihh are moderately expressed in colon ade-
nomas, but to a much lesser extent in carcinomas. Our
results suggest that histological tumor grade does not sig-
nificantly correlate with the level of expression of GATA-6
in cancer cells, although earlier in vitro studies have sug-
gested that GATA-6 expression is strongest in the most
undifferentiated colon carcinoma cells [10]. In our pre-
liminary analyses, we found that intense GATA-6 immu-
noreactivity is characteristic of the border regions of
malignant tissue and the invasive parts of the carcinoma.
This may well be due to stromal signals that induce GATA-
6 in the adjacent tumor regions.
The expression patterns of GATA-4 and GATA-6 in the
longitudinal and crypt-villus axes are in accordance with
the results of earlier studies on murine gastrointestinal
tract [15]. In human fetuses, GATA-4 was found in the
small intestine [39], and this expression is sustained in
mature mucosa as well (this study). Also an earlier study
based on RT-PCR analysis demonstrated the absence of
GATA-4 from colon, and its presence in stomach [40]. A
gene for hydrogen/potassium adenosine triphosphatase
(H+/K+ ATPase) in the stomach, responsible for acid pro-
duction in the parietal cells, is regulated by the gastroin-
testinal GATA factors [41]. In the parietal cells, GATA-6
positivity varied from one cell to another. This may reflect
the fact that the structure and activity of the parietal cells
depend on their developmental stage and location in the
glands [31]. In our study, Ihh expression was intense in
normal gastric glands, whereas Fukaya et al. [24] found
Ihh only in gastric pits. The same Ihh antibodies were
used in both studies, but the samples in Fukaya's study
were neoplastic and their matched tissues. These differ-
ences are likely to explain the discrepancies between the
two reports.
GATA-4, GATA-6, and Ihh protein expression in neoplastic gastrointestinal mucosa Figure 4
GATA-4, GATA-6, and Ihh protein expression in neoplastic gastrointestinal mucosa. GATA-4, GATA-6, and Ihh 
are strongly expressed in intestinal metaplasia of the stomach (A, A', and A", respectively). The insets in A, A' and A" represent 
magnifications of cardiac glands. GATA-4 and GATA-6 are strongly expressed in neuroendocrine cell hyperplasia (B and B', 
respectively) in contrast to no or little expression of Ihh (B"). GATA-4 is detected neither in colon adenomas (C) nor carcino-
mas (D). The expressions of GATA-6 and Ihh are weak in adenomas, but enhanced in high grade dysplasias (C' and C" with 
insets). Little GATA-6 is found in the carcinoma tissue (D'). Ihh is not present in colon carcinoma (D"). Scale bar = 50 μm.BMC Gastroenterology 2008, 8:9 http://www.biomedcentral.com/1471-230X/8/9
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The expression of GATA-4, GATA-6, and Ihh in gastrointestinal mucosa in a) longitudinal and b) crypt-villus axes Figure 5
The expression of GATA-4, GATA-6, and Ihh in gastrointestinal mucosa in a) longitudinal and b) crypt-villus 
axes. A summary based on immunohistochemical results: (a) GATA-4 expression diminishes towards the distal end, whereas 
GATA-6 expression shows only little reduction in the longitudinal axis. Ihh is present very modestly along the gastrointestinal 
tract, except for the strong expression in the stomach. The expression patterns are based on the number of positive cells 
detected and the intensity of staining: – no expression, + individual positive cells or small areas with low expression, ++ 
patches of moderate expression, +++ large areas of moderate or strong expression, ND not detected. (b) GATA-4, GATA-6, 
and Ihh expression are presented in columns divided into three mucosal layers: surface layer (Sur), middle layer (Mid) and base 
(Bas). Each section of the GI tract is represented (STO = stomach, DUO = duodenum, ILE = ileum, COL = colon). The inten-
sity of the color demonstrates the intensity of expression along the crypt villus-axis. White depicts undetectable expression.
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GATA proteins have been suggested to regulate genes
encoding for TFF and mucin proteins [16,17] which pro-
tect the mucosa from harmful exogenous agents and are
related to abnormal tissue growth and carcinogenesis [42-
44]. It is of interest that both GATA-4 and GATA-6 pro-
teins are present in TFF-expressing pit and surface epithe-
lial cells. We detected GATA-6 also in human goblet cells,
and others have found GATA-4 in murine goblet cells that
express the mucin protein MUC2 [17]. Furthermore, TFF
and mucin proteins have been shown to be present in
esophageal and gastric metaplasias [45-47], similarly to
GATA-4 and GATA-6 (this study). Particularly MUC2
expression in Barrett's metaplasia is considered to indicate
a higher risk for carcinoma [46]. Collectively, these data
support the interrelationship of GATA proteins, TFF, and
mucins in the gastrointestinal endoderm.
A previous study suggested that inactivation of the Gata4
gene by methylation could be crucial during carcinogene-
sis [48]. It is tempting to speculate that GATA-4, in addi-
tion to promoting cellular differentiation in the human
gastrointestinal tract, is also involved in the suppression
of abnormal growth in the proximal gastrointestinal tract.
When GATA-4 is inactivated by methylation, the fate of
the cells may proceed towards malignant alterations. Like-
wise, the role of GATA-6 in neoplasias is controversial. In
vascular smooth muscle cells, GATA-6 inhibits injury
induced hyperplasia [49]. It is noteworthy that GATA-6 is
present in adrenocortical adenomas, but diminishes in
carcinomas, suggesting that also Gata6  may become
methylated during tumorigenesis [50]. GATA-6 has been
suggested to induce cell cycle arrest [51], to inhibit apop-
tosis and induce malignant cell growth [52]. Our prelimi-
nary results suggest high expression of GATA-6 in the
invasive edges of the carcinomas. The enhanced GATA-6
action in these tumor areas may be linked to uncontrolled
growth of the tumor cells. More detailed studies are, how-
ever, required to establish the role of GATA-6 in the gas-
trointestinal tumor growth.
Conclusion
The specific expression patterns of GATA-4 and GATA-6
and their abundance in the gastrointestinal mucosa (sum-
marized in Figure 5) suggest that they have distinctive and
central functions in the gut. Thus, GATA-4 may well be
involved in digestive and absorptive functions in the prox-
imal gut, whereas GATA-6 is likely to have a more ubiqui-
tous task throughout the gastrointestinal tract. GATA-4 is
expressed abundantly in the cell population programmed
to differentiate, and GATA-6, on the contrary, is associated
with the proliferative compartment of the mucosal cells.
GATA-4 is abundant in intestinal metaplasias and GATA-
6 in dysplastic lesions of the colon. Along with GATA-6,
Ihh is also induced during abnormal growth. The signifi-
cance of these factors in gastrointestinal neoplasia
remains open, however. The present data offer a firm basis
for further investigation of the role of GATA factors and
Ihh in normal as well as pathological conditions of
human gastrointestinal mucosa.
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